RT @EdoajoEric: This is not a homogeneous disease! It has subclasses! We need to identify and define them and differentiate treatment accor…
RT @progdoctalk: 1/n Delighted to share our latest work exploring phenotypes in #COVID19 ARDS with @david_furfaro, Max O'Donnell, Dan Brodi…
RT @EdoajoEric: This is not a homogeneous disease! It has subclasses! We need to identify and define them and differentiate treatment accor…
RT @farid__jalali: This is a significant study, proposing that steroids can increase mortality (or at least lack benefit) in a subgroup of…
RT @EdoajoEric: This is not a homogeneous disease! It has subclasses! We need to identify and define them and differentiate treatment accor…
This is not a homogeneous disease! It has subclasses! We need to identify and define them and differentiate treatment accordingly. Scalpel > sledgehammer. Great hypothesis generating research here.
RT @progdoctalk: 1/n Delighted to share our latest work exploring phenotypes in #COVID19 ARDS with @david_furfaro, Max O'Donnell, Dan Brodi…
RT @progdoctalk: 1/n Delighted to share our latest work exploring phenotypes in #COVID19 ARDS with @david_furfaro, Max O'Donnell, Dan Brodi…
This is a significant study, proposing that steroids can increase mortality (or at least lack benefit) in a subgroup of COVID19 ARDS, caveat being non-randomized: 👇👇👇👇👇 https://t.co/ZhIdTR0ylE
RT @david_furfaro: I'm very proud and excited to share our research on COVID-19 ARDS Using LCA, we found two classes, similar to existing…
RT @progdoctalk: 1/n Delighted to share our latest work exploring phenotypes in #COVID19 ARDS with @david_furfaro, Max O'Donnell, Dan Brodi…
RT @david_furfaro: I'm very proud and excited to share our research on COVID-19 ARDS Using LCA, we found two classes, similar to existing…
RT @david_furfaro: I'm very proud and excited to share our research on COVID-19 ARDS Using LCA, we found two classes, similar to existing…
RT @progdoctalk: 1/n Delighted to share our latest work exploring phenotypes in #COVID19 ARDS with @david_furfaro, Max O'Donnell, Dan Brodi…
RT @progdoctalk: 1/n Delighted to share our latest work exploring phenotypes in #COVID19 ARDS with @david_furfaro, Max O'Donnell, Dan Brodi…
RT @progdoctalk: 1/n Delighted to share our latest work exploring phenotypes in #COVID19 ARDS with @david_furfaro, Max O'Donnell, Dan Brodi…
RT @progdoctalk: 1/n Delighted to share our latest work exploring phenotypes in #COVID19 ARDS with @david_furfaro, Max O'Donnell, Dan Brodi…
Must read.
RT @progdoctalk: 1/n Delighted to share our latest work exploring phenotypes in #COVID19 ARDS with @david_furfaro, Max O'Donnell, Dan Brodi…
1/n Delighted to share our latest work exploring phenotypes in #COVID19 ARDS with @david_furfaro, Max O'Donnell, Dan Brodie, Carolyn Calfee and several others. Published online @ATSBlueEditor. So what did we find..........was it HTE with steroids? https
Hyper- and hypoinflammatory ARDS subphenotypes strike again- this time in severe COVID-19. Congrats, @david_furfaro and team. I know how hard you worked on this.
Congrats, Dave! @david_furfaro
I'm very proud and excited to share our research on COVID-19 ARDS Using LCA, we found two classes, similar to existing ARDS subphenotypes, with different mortality and different response to corticosteroids. https://t.co/NbQnWckr7n @ATSBlueEditor @atscom